I wonder if the extensive ICON validation process will be the final stamp of approval just prior to AMBS selling it. IOW, a buyer is waiting in the wings to buy Lympro once the validation is completed and successful. The company needs money in a hurry and I am not sure Lympro will be adopted fast enough for AMBS to keep the lights on.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.